{"transactions":[{"id":833190,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-03-19T22:35:34.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":118969,"price":6.423,"value":764137.887,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 457,500 RSUs."}],"balance_after":1078922,"source":{"system":"sec-edgar","filing":"0001610717-26-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071726000124/form4.xml","form_type":"4"}},{"id":919140,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:22:15.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":980000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":980000,"derivative":{"exercise_price":6.09,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":980000},"source":{"system":"sec-edgar","filing":"0001610717-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071726000039/form4.xml","form_type":"4"}},{"id":919139,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-04T21:22:15.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2027, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 698,750 RSUs."}],"balance_after":1197891,"source":{"system":"sec-edgar","filing":"0001610717-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071726000039/form4.xml","form_type":"4"}},{"id":1003492,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Class A Common Stock","published_at":"2025-11-10T21:05:32.000Z","date":"2025-11-06","kind":"sale","planned":true,"acquired":false,"shares":101793,"price":4.5377,"value":461906.0961,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on August 27, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.50 to $4.62, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 488,750 restricted stock units."}],"balance_after":987891,"source":{"system":"sec-edgar","filing":"0001610717-25-000372","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000372/form4.xml","form_type":"4"}},{"id":1030383,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Stock Units (PSUs)","published_at":"2025-09-30T22:40:05.000Z","date":"2025-09-26","kind":"grant","planned":false,"acquired":true,"shares":285000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/3 of the PSUs vest upon the achievement of each of three clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":285000,"derivative":{"underlying":"Common Stock","underlying_shares":285000},"source":{"system":"sec-edgar","filing":"0001610717-25-000357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000357/form4.xml","form_type":"4"}},{"id":1030382,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-30T22:40:05.000Z","date":"2025-09-26","kind":"grant","planned":false,"acquired":true,"shares":570000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from September 26, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":570000,"derivative":{"exercise_price":2.9,"expiration_date":"2035-09-25","underlying":"Common Stock","underlying_shares":570000},"source":{"system":"sec-edgar","filing":"0001610717-25-000357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000357/form4.xml","form_type":"4"}},{"id":1107593,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Stock Units","published_at":"2025-06-17T20:09:02.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PSU represented a contingent right to receive one (1) share of common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each PSU represented a contingent right to receive one (1) share of common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each PSU represented a contingent right to receive one (1) share of common stock upon vesting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001610717-25-000234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000234/form4.xml","form_type":"4"}},{"id":1107592,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-06-17T20:09:02.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":55511,"price":2.6889,"value":149263.5279,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 488,750 restricted stock units."}],"balance_after":1089684,"source":{"system":"sec-edgar","filing":"0001610717-25-000234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000234/form4.xml","form_type":"4"}},{"id":1107591,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-06-17T20:09:02.000Z","date":"2025-06-13","kind":"exercise","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the vesting of performance stock units (\"PSUs\") initially granted on February 2, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 488,750 restricted stock units."}],"balance_after":1145195,"source":{"system":"sec-edgar","filing":"0001610717-25-000234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000234/form4.xml","form_type":"4"}},{"id":1195472,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-20T20:34:40.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":37656,"price":0.599,"value":22555.944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 488,750 RSUs."}],"balance_after":995195,"source":{"system":"sec-edgar","filing":"0001610717-25-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000086/form4.xml","form_type":"4"}},{"id":1280103,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-06T22:54:34.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":390000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/24th of the shares subject to the option vest on each monthly anniversary measured from the Vesting Commencement Date, such that 100% of the shares subject to the option will be fully vested and exercisable on the second anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":390000,"derivative":{"exercise_price":0.864,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001610717-25-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000016/form4.xml","form_type":"4"}},{"id":1280102,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-06T22:54:34.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 4, 2025 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":800000,"derivative":{"exercise_price":0.864,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001610717-25-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000016/form4.xml","form_type":"4"}},{"id":1280101,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-06T22:54:34.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Constitute RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest annually on March 15 of each year, with the first 50% vesting on March 15, 2026, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 572,500 RSUs."}],"balance_after":1032851,"source":{"system":"sec-edgar","filing":"0001610717-25-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000016/form4.xml","form_type":"4"}},{"id":1280100,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-06T22:54:34.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":837851,"source":{"system":"sec-edgar","filing":"0001610717-25-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000016/form4.xml","form_type":"4"}},{"id":1425026,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Stock Units (PSUs)","published_at":"2024-08-22T21:58:38.000Z","date":"2024-08-20","kind":"exercise","planned":false,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vested on December 17, 2023 upon achievement of a certain performance-based milestone. In connection with the vesting reported herein, the remaining 50% of the PSUs vested upon achievement of a certain performance-based milestone."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents vesting of a Performance Stock Unit (\"PSU\") award initially granted on August 10, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vested on December 17, 2023 upon achievement of a certain performance-based milestone. In connection with the vesting reported herein, the remaining 50% of the PSUs vested upon achievement of a certain performance-based milestone."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vested on December 17, 2023 upon achievement of a certain performance-based milestone. In connection with the vesting reported herein, the remaining 50% of the PSUs vested upon achievement of a certain performance-based milestone."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001610717-24-000432","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000432/form4.xml","form_type":"4"}},{"id":1425025,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-08-22T21:58:38.000Z","date":"2024-08-20","kind":"sale","planned":false,"acquired":false,"shares":13898,"price":1.2291,"value":17082.0318,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs reported herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 197,500 restricted stock units."}],"balance_after":657851,"source":{"system":"sec-edgar","filing":"0001610717-24-000432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000432/form4.xml","form_type":"4"}},{"id":1425024,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-08-22T21:58:38.000Z","date":"2024-08-20","kind":"exercise","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents vesting of a Performance Stock Unit (\"PSU\") award initially granted on August 10, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 197,500 restricted stock units."}],"balance_after":671749,"source":{"system":"sec-edgar","filing":"0001610717-24-000432","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000432/form4.xml","form_type":"4"}},{"id":1558227,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-28T23:12:49.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":false,"shares":109768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person previously transferred 9,768 shares subject to this stock option to a family member."}],"balance_after":0,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":109768},"source":{"system":"sec-edgar","filing":"0001610717-24-000190","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000190/form4.xml","form_type":"4"}},{"id":1558226,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-28T23:12:49.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":true,"shares":109768,"price":1.5749,"value":172873.6232,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 197,500 restricted stock units."}],"balance_after":634249,"source":{"system":"sec-edgar","filing":"0001610717-24-000190","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000190/form4.xml","form_type":"4"}},{"id":1564606,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-03-21T20:40:09.000Z","date":"2024-03-19","kind":"sale","planned":false,"acquired":false,"shares":20223,"price":2.0855,"value":42175.0665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 197,500 restricted stock units."}],"balance_after":524481,"source":{"system":"sec-edgar","filing":"0001610717-24-000178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000178/form4.xml","form_type":"4"}},{"id":1674994,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Stock Units (PSUs)","published_at":"2024-01-20T01:44:59.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":260000,"derivative":{"underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001610717-24-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000036/form4.xml","form_type":"4"}},{"id":1674993,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-20T01:44:59.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 18, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":420000,"derivative":{"exercise_price":1.68,"expiration_date":"2034-01-17","underlying":"Common Stock","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001610717-24-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000036/form4.xml","form_type":"4"}},{"id":1674992,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-20T01:44:59.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on March 15 of each year, with the first 1/3rd vesting on March 15, 2025, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 251,250 RSUs."}],"balance_after":544704,"source":{"system":"sec-edgar","filing":"0001610717-24-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000036/form4.xml","form_type":"4"}},{"id":1700665,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-12-22T21:16:04.000Z","date":"2023-12-20","kind":"sale","planned":false,"acquired":false,"shares":13551,"price":1.3807,"value":18709.8657,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 161,250 restricted stock units."}],"balance_after":454704,"source":{"system":"sec-edgar","filing":"0001610717-23-000423","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000423/form4.xml","form_type":"4"}},{"id":1704437,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Stock Units (PSUs)","published_at":"2023-12-20T00:57:37.000Z","date":"2023-12-17","kind":"exercise","planned":false,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents partial vesting of a Performance Stock Unit (\"PSU\") award initially granted on August 10, 2022."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents partial vesting of a Performance Stock Unit (\"PSU\") award initially granted on August 10, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. In connection with the vesting reported herein, 50% of the PSUs vested upon achievement of a certain performance-based milestone. The remaining 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. In connection with the vesting reported herein, 50% of the PSUs vested upon achievement of a certain performance-based milestone. The remaining 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2024."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001610717-23-000411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000411/form4.xml","form_type":"4"}},{"id":1704436,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-12-20T00:57:37.000Z","date":"2023-12-17","kind":"exercise","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents partial vesting of a Performance Stock Unit (\"PSU\") award initially granted on August 10, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 161,250 restricted stock units."}],"balance_after":468255,"source":{"system":"sec-edgar","filing":"0001610717-23-000411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000411/form4.xml","form_type":"4"}},{"id":1774526,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-09-22T23:13:47.000Z","date":"2023-09-22","kind":"sale","planned":false,"acquired":false,"shares":14601,"price":1.3004,"value":18987.1404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 161,250 restricted stock units."}],"balance_after":430755,"source":{"system":"sec-edgar","filing":"0001610717-23-000297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000297/form4.xml","form_type":"4"}},{"id":1774525,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-09-22T23:13:47.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Performance Stock Units (\"PSUs\") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The second milestone vesting condition was determined to be satisfied upon which the remaining 50% of the PSUs vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 161,250 restricted stock units."}],"balance_after":445356,"source":{"system":"sec-edgar","filing":"0001610717-23-000297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000297/form4.xml","form_type":"4"}},{"id":1880795,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-23T20:52:51.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":false,"shares":16535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":119536,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":16535},"source":{"system":"sec-edgar","filing":"0001610717-23-000061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000061/form4.xml","form_type":"4"}},{"id":1880794,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-23T20:52:51.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":true,"shares":16535,"price":1.5749,"value":26040.9715,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 161,250 restricted stock units."}],"balance_after":405356,"source":{"system":"sec-edgar","filing":"0001610717-23-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000061/form4.xml","form_type":"4"}},{"id":1944189,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-03-20T22:43:33.000Z","date":"2023-03-16","kind":"sale","planned":false,"acquired":false,"shares":7121,"price":1.8805,"value":13391.0405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 161,250 restricted stock units."}],"balance_after":388821,"source":{"system":"sec-edgar","filing":"0001140361-23-012618","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036123012618/form4.xml","form_type":"4"}},{"id":2030314,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units (PSUs)","published_at":"2023-02-06T21:50:54.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one (1) share of Common Stock upon vesting. 1/2 of the PSUs vest upon the achievement of each of two clinical milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":300000,"derivative":{"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001567619-23-001930","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761923001930/doc1.xml","form_type":"4"}},{"id":2030313,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-06T21:50:54.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":315000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":315000,"derivative":{"exercise_price":2.59,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":315000},"source":{"system":"sec-edgar","filing":"0001567619-23-001930","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761923001930/doc1.xml","form_type":"4"}},{"id":2030312,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-02-06T21:50:54.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on Febrary 2 of each year, with the first 1/3rd vesting on February 2, 2024, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 180,000 RSUs."}],"balance_after":395942,"source":{"system":"sec-edgar","filing":"0001567619-23-001930","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761923001930/doc1.xml","form_type":"4"}},{"id":2186635,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units (PSUs)","published_at":"2022-08-12T21:01:21.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2023 and 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2023 and 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2023 and 50% of the PSUs vest upon achievement of a certain performance-based milestone by 12/31/2024."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001567619-22-015868","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922015868/doc1.xml","form_type":"4"}},{"id":2186634,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-12T21:01:21.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from August 10, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":450000,"derivative":{"exercise_price":1.59,"expiration_date":"2032-08-09","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001567619-22-015868","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922015868/doc1.xml","form_type":"4"}},{"id":2203770,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-21T20:10:43.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":14911,"price":1.4222,"value":21206.4242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSU of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 75,000 restricted stock units."}],"balance_after":290942,"source":{"system":"sec-edgar","filing":"0001567619-22-014299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014299/doc1.xml","form_type":"4"}},{"id":2203769,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-21T20:10:43.000Z","date":"2022-07-19","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Performance Stock Units (\"PSUs\") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The first milestone vesting condition was determined to be satisfied upon which 50% of the PSUs vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 75,000 restricted stock units."}],"balance_after":305853,"source":{"system":"sec-edgar","filing":"0001567619-22-014299","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014299/doc1.xml","form_type":"4"}},{"id":2274535,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-11T20:51:34.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":24189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.945,"expiration_date":"2023-02-25","underlying":"Common Stock","underlying_shares":24189},"source":{"system":"sec-edgar","filing":"0001567619-22-010091","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922010091/doc1.xml","form_type":"4"}},{"id":2274534,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-11T20:51:34.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":66742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.945,"expiration_date":"2023-02-25","underlying":"Common Stock","underlying_shares":66742},"source":{"system":"sec-edgar","filing":"0001567619-22-010091","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922010091/doc1.xml","form_type":"4"}},{"id":2274533,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-11T20:51:34.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":24189,"price":0.945,"value":22858.605,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 75,000 restricted stock units."}],"balance_after":265853,"source":{"system":"sec-edgar","filing":"0001567619-22-010091","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922010091/doc1.xml","form_type":"4"}},{"id":2274532,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-11T20:51:34.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":66742,"price":0.945,"value":63071.19,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 75,000 restricted stock units."}],"balance_after":241664,"source":{"system":"sec-edgar","filing":"0001567619-22-010091","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922010091/doc1.xml","form_type":"4"}},{"id":2411398,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T21:49:39.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":450000,"derivative":{"exercise_price":4.13,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001567619-22-002521","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002521/doc1.xml","form_type":"4"}},{"id":2411397,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-04T21:49:39.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 75,000 RSUs."}],"balance_after":174922,"source":{"system":"sec-edgar","filing":"0001567619-22-002521","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002521/doc1.xml","form_type":"4"}},{"id":2534393,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Stock Units (PSUs)","published_at":"2021-10-26T20:30:31.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."}],"balance_after":80000,"derivative":{"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001567619-21-018720","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018720/doc1.xml","form_type":"4"}},{"id":2534392,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-26T20:30:31.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":100000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-10-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-21-018720","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018720/doc1.xml","form_type":"4"}},{"id":2603418,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-13T21:22:02.000Z","date":"2021-08-11","kind":"exercise","acquired":false,"shares":92113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Exercise of September 2021 expiring stock options with cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.1339,"expiration_date":"2021-09-20","underlying":"Common Stock","underlying_shares":92113},"source":{"system":"sec-edgar","filing":"0001567619-21-015554","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921015554/doc1.xml","form_type":"4"}},{"id":2603417,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-13T21:22:02.000Z","date":"2021-08-11","kind":"exercise","acquired":true,"shares":92113,"price":1.1339,"value":104446.9307,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities held has been adjusted to reflect the transfer of 40 shares previously owned directly to Sean A. McCarthy 2018 Trust."}],"balance_after":99922,"source":{"system":"sec-edgar","filing":"0001567619-21-015554","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921015554/doc1.xml","form_type":"4"}},{"id":2660266,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-21T19:51:22.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":100000,"price":7.0447,"value":704470.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $6.88 to $7.135, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee."}],"balance_after":93118,"source":{"system":"sec-edgar","filing":"0001567619-21-012419","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921012419/doc1.xml","form_type":"4"}},{"id":2665706,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T01:49:21.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":10,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":66742,"derivative":{"exercise_price":0.945,"expiration_date":"2023-02-25","underlying":"Common Stock","underlying_shares":10},"source":{"system":"sec-edgar","filing":"0001567619-21-012252","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921012252/doc1.xml","form_type":"4"}},{"id":2665705,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T01:49:21.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":30,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":92113,"derivative":{"exercise_price":1.1339,"expiration_date":"2021-09-20","underlying":"Common Stock","underlying_shares":30},"source":{"system":"sec-edgar","filing":"0001567619-21-012252","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921012252/doc1.xml","form_type":"4"}},{"id":2665704,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-17T01:49:21.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":10,"price":0.945,"value":9.45,"ownership":{"direct":true},"balance_after":7849,"source":{"system":"sec-edgar","filing":"0001567619-21-012252","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921012252/doc1.xml","form_type":"4"}},{"id":2665703,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-17T01:49:21.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":30,"price":1.1339,"value":34.017,"ownership":{"direct":true},"balance_after":7839,"source":{"system":"sec-edgar","filing":"0001567619-21-012252","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921012252/doc1.xml","form_type":"4"}},{"id":2677101,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-08T17:10:22.000Z","date":"2019-09-30","kind":"gift","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,006 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 31, 2021 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities directly held has been adjusted to reflect the transfer of (i) 2,473 shares pursuant to a domestic relations order on July 9, 2018, (ii) 193,118 shares to Sean A. McCarthy 2018 Trust."}],"balance_after":7809,"source":{"system":"sec-edgar","filing":"0001567619-21-011808","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921011808/doc1.xml","form_type":"4"}},{"id":2760524,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T21:37:50.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":92143,"derivative":{"exercise_price":1.1339,"expiration_date":"2021-09-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-21-007541","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921007541/doc1.xml","form_type":"4"}},{"id":2760523,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-02T21:37:50.000Z","date":"2021-03-31","kind":"sale","acquired":false,"shares":100000,"price":7.4947,"value":749470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $7.35 to $7.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":206894,"source":{"system":"sec-edgar","filing":"0001567619-21-007541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921007541/doc1.xml","form_type":"4"}},{"id":2760522,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-02T21:37:50.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":100000,"price":1.1339,"value":113390.0,"ownership":{"direct":true},"balance_after":306894,"source":{"system":"sec-edgar","filing":"0001567619-21-007541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921007541/doc1.xml","form_type":"4"}},{"id":2818996,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-02T21:58:28.000Z","date":"2021-02-27","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 26, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":200000,"derivative":{"exercise_price":7.85,"expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001567619-21-005396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921005396/doc1.xml","form_type":"4"}},{"id":2818995,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T21:58:28.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 26, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":400000,"derivative":{"exercise_price":7.85,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001567619-21-005396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921005396/doc1.xml","form_type":"4"}},{"id":2930964,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-29T00:52:02.000Z","date":"2020-12-23","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":192143,"derivative":{"exercise_price":1.1339,"expiration_date":"2021-09-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-20-021619","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920021619/doc1.xml","form_type":"4"}},{"id":2930963,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-29T00:52:02.000Z","date":"2020-12-23","kind":"exercise","acquired":true,"shares":100000,"price":1.1339,"value":113390.0,"ownership":{"direct":true},"balance_after":206894,"source":{"system":"sec-edgar","filing":"0001567619-20-021619","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920021619/doc1.xml","form_type":"4"}},{"id":2954881,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-07T21:58:45.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":930,"price":6.392,"value":5944.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"930 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":106894,"source":{"system":"sec-edgar","filing":"0001567619-20-020707","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920020707/doc1.xml","form_type":"4"}},{"id":3023515,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-23T20:53:51.000Z","date":"2020-09-21","kind":"exercise","acquired":false,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option are fully vested and exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person previously transferred an aggregate of 738,586 shares underlying certain stock options, including 417,802 shares subject to this stock option, to an immediate family member."}],"balance_after":0,"derivative":{"exercise_price":6.6147,"expiration_date":"2025-08-25","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001567619-20-017051","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920017051/doc1.xml","form_type":"4"}},{"id":3023514,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-23T20:53:51.000Z","date":"2020-09-21","kind":"exercise","acquired":true,"shares":20500,"price":6.6147,"value":135601.35,"ownership":{"direct":true},"balance_after":105964,"source":{"system":"sec-edgar","filing":"0001567619-20-017051","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920017051/doc1.xml","form_type":"4"}},{"id":3126535,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-02T20:54:10.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":1158,"price":5.1085,"value":5915.643,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1,158 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":85464,"source":{"system":"sec-edgar","filing":"0001567619-20-011542","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920011542/doc1.xml","form_type":"4"}},{"id":3148526,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-14T20:31:09.000Z","date":"2020-05-12","kind":"exercise","acquired":false,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":292143,"derivative":{"exercise_price":1.1339,"expiration_date":"2021-09-20","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001567619-20-010115","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920010115/doc1.xml","form_type":"4"}},{"id":3148525,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-14T20:31:09.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":36000,"price":15,"value":540000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":84306,"source":{"system":"sec-edgar","filing":"0001567619-20-010115","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920010115/doc1.xml","form_type":"4"}},{"id":3148524,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-14T20:31:09.000Z","date":"2020-05-12","kind":"exercise","acquired":true,"shares":36000,"price":1.1339,"value":40820.4,"ownership":{"direct":true},"balance_after":120306,"source":{"system":"sec-edgar","filing":"0001567619-20-010115","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920010115/doc1.xml","form_type":"4"}},{"id":3262239,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T23:37:47.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2020 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":500000,"derivative":{"exercise_price":7.13,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001567619-20-004345","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920004345/doc1.xml","form_type":"4"}},{"id":3340612,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-16T21:20:54.000Z","date":"2019-11-30","kind":"grant","acquired":true,"shares":1080,"price":5.321,"value":5746.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1,080 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":84306,"source":{"system":"sec-edgar","filing":"0001567619-19-023150","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919023150/doc1.xml","form_type":"4"}},{"id":3501770,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-04T20:04:42.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":695,"price":8.211,"value":5706.645,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"695 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":83226,"source":{"system":"sec-edgar","filing":"0001567619-19-012666","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919012666/doc1.xml","form_type":"4"}},{"id":3683577,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T23:56:00.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2019 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":300000,"derivative":{"exercise_price":16.85,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001567619-19-001862","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919001862/doc1.xml","form_type":"4"}},{"id":3740839,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-06T18:57:00.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":468,"price":11.73,"value":5489.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"468 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":82531,"source":{"system":"sec-edgar","filing":"0001567619-18-007415","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918007415/doc1.xml","form_type":"4"}},{"id":3773857,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-05T21:14:27.000Z","date":"2018-11-02","kind":"exercise","acquired":false,"shares":1156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015."}],"balance_after":136071,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":1156},"source":{"system":"sec-edgar","filing":"0001567619-18-005081","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/doc1.xml","form_type":"4"}},{"id":3773856,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-05T21:14:27.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":5370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015."}],"balance_after":137227,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":5370},"source":{"system":"sec-edgar","filing":"0001567619-18-005081","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/doc1.xml","form_type":"4"}},{"id":3773855,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-05T21:14:27.000Z","date":"2018-11-02","kind":"sale","acquired":false,"shares":1156,"price":15.007,"value":17348.092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $15.00 to $15.02, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":82063,"source":{"system":"sec-edgar","filing":"0001567619-18-005081","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/doc1.xml","form_type":"4"}},{"id":3773854,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-05T21:14:27.000Z","date":"2018-11-02","kind":"exercise","acquired":true,"shares":1156,"price":1.5749,"value":1820.5844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":83219,"source":{"system":"sec-edgar","filing":"0001567619-18-005081","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/doc1.xml","form_type":"4"}},{"id":3773853,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-05T21:14:27.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":5270,"price":15,"value":79050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":82063,"source":{"system":"sec-edgar","filing":"0001567619-18-005081","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/doc1.xml","form_type":"4"}},{"id":3773852,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-05T21:14:27.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":100,"price":15.005,"value":1500.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":87333,"source":{"system":"sec-edgar","filing":"0001567619-18-005081","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/doc1.xml","form_type":"4"}},{"id":3773851,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-05T21:14:27.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":5370,"price":1.5749,"value":8457.213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":87433,"source":{"system":"sec-edgar","filing":"0001567619-18-005081","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/doc1.xml","form_type":"4"}},{"id":3823069,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-06T23:14:42.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":13052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015."}],"balance_after":142597,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":13052},"source":{"system":"sec-edgar","filing":"0001567619-18-002231","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918002231/doc1.xml","form_type":"4"}},{"id":3823068,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-09-06T23:14:42.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":13052,"price":21.862,"value":285342.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $21.65 to $22.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":82063,"source":{"system":"sec-edgar","filing":"0001567619-18-002231","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918002231/doc1.xml","form_type":"4"}},{"id":3823067,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-09-06T23:14:42.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":13052,"price":1.5749,"value":20555.5948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":95115,"source":{"system":"sec-edgar","filing":"0001567619-18-002231","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918002231/doc1.xml","form_type":"4"}},{"id":3870962,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-09T22:15:51.000Z","date":"2018-07-05","kind":"exercise","acquired":false,"shares":4497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015."}],"balance_after":155649,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":4497},"source":{"system":"sec-edgar","filing":"0001140361-18-031945","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031945/doc1.xml","form_type":"4"}},{"id":3870961,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-09T22:15:51.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":4497,"price":25.0586,"value":112688.5242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $25.00 to $25.23, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":82063,"source":{"system":"sec-edgar","filing":"0001140361-18-031945","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031945/doc1.xml","form_type":"4"}},{"id":3870960,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-09T22:15:51.000Z","date":"2018-07-05","kind":"exercise","acquired":true,"shares":4497,"price":1.5749,"value":7082.3253,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":86560,"source":{"system":"sec-edgar","filing":"0001140361-18-031945","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031945/doc1.xml","form_type":"4"}},{"id":3871654,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-06T22:52:58.000Z","date":"2018-07-03","kind":"exercise","acquired":false,"shares":2028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015."}],"balance_after":160146,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":2028},"source":{"system":"sec-edgar","filing":"0001140361-18-031810","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031810/doc1.xml","form_type":"4"}},{"id":3871653,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-06T22:52:58.000Z","date":"2018-07-03","kind":"sale","acquired":false,"shares":2028,"price":25.089,"value":50880.492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $25.00 to $25.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":82063,"source":{"system":"sec-edgar","filing":"0001140361-18-031810","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031810/doc1.xml","form_type":"4"}},{"id":3871652,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-06T22:52:58.000Z","date":"2018-07-03","kind":"exercise","acquired":true,"shares":2028,"price":1.5749,"value":3193.8972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":84091,"source":{"system":"sec-edgar","filing":"0001140361-18-031810","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031810/doc1.xml","form_type":"4"}},{"id":3874120,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-03T22:50:37.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":13052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015."}],"balance_after":162174,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":13052},"source":{"system":"sec-edgar","filing":"0001140361-18-031327","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031327/doc1.xml","form_type":"4"}},{"id":3874119,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-03T22:50:37.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":13052,"price":23.4223,"value":305707.8596,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $22.56 to $23.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Share numbers reflect the transfer of (i) 77,118 shares to the reporting person and (ii) 77,119 shares to the reporting person's ex-wife, from McCarthy Family Trust dated August 9, 2001, Sean A. McCarthy and Jeanette J. McCarthy, Trustees, pursuant to a domestic relations order."}],"balance_after":82063,"source":{"system":"sec-edgar","filing":"0001140361-18-031327","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031327/doc1.xml","form_type":"4"}},{"id":3874118,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-03T22:50:37.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":13052,"price":1.5749,"value":20555.5948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Share numbers reflect the transfer of (i) 77,118 shares to the reporting person and (ii) 77,119 shares to the reporting person's ex-wife, from McCarthy Family Trust dated August 9, 2001, Sean A. McCarthy and Jeanette J. McCarthy, Trustees, pursuant to a domestic relations order."}],"balance_after":95115,"source":{"system":"sec-edgar","filing":"0001140361-18-031327","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031327/doc1.xml","form_type":"4"}},{"id":3904513,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-06-05T23:45:28.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":302,"price":17.901,"value":5406.102,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were acquired under the issuer's Employee Stock Purchase Plan on May 31, 2018."}],"balance_after":4945,"source":{"system":"sec-edgar","filing":"0001140361-18-027474","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118027474/doc1.xml","form_type":"4"}},{"id":3949506,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-02T22:25:25.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":19578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015"}],"balance_after":175226,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":19578},"source":{"system":"sec-edgar","filing":"0001140361-18-021344","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118021344/doc1.xml","form_type":"4"}},{"id":3949505,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-02T22:25:25.000Z","date":"2018-05-01","kind":"sale","acquired":false,"shares":19578,"price":26.5473,"value":519743.0394,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $26.22 to $26.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4643,"source":{"system":"sec-edgar","filing":"0001140361-18-021344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118021344/doc1.xml","form_type":"4"}},{"id":3949504,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-02T22:25:25.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":19578,"price":1.5749,"value":30833.3922,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":24221,"source":{"system":"sec-edgar","filing":"0001140361-18-021344","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118021344/doc1.xml","form_type":"4"}},{"id":4013955,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T21:55:15.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":62,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":66752,"derivative":{"exercise_price":0.945,"expiration_date":"2023-02-25","underlying":"Common Stock","underlying_shares":62},"source":{"system":"sec-edgar","filing":"0001140361-18-012008","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012008/doc1.xml","form_type":"4"}},{"id":4013954,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T21:55:15.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":328143,"derivative":{"exercise_price":1.1339,"expiration_date":"2021-09-20","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-18-012008","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012008/doc1.xml","form_type":"4"}},{"id":4013953,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T21:55:15.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":10516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in 48 substantially equal monthly installments starting on the last day of January 2015."}],"balance_after":194804,"derivative":{"exercise_price":1.5749,"expiration_date":"2025-02-08","underlying":"Common Stock","underlying_shares":10516},"source":{"system":"sec-edgar","filing":"0001140361-18-012008","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012008/doc1.xml","form_type":"4"}},{"id":4013952,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":57063,"kind":"person","name":"McCarthy Sean A.","position":1,"cik":"0001654058","reported_name":"McCarthy Sean A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-03-05T21:55:15.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":19578,"price":29.428,"value":576141.384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.90, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4643,"source":{"system":"sec-edgar","filing":"0001140361-18-012008","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012008/doc1.xml","form_type":"4"}}],"next_cursor":"2018-03-05T21:55:15.000000Z,4013952"}